Literature DB >> 7790939

High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases.

T Ohnishi1, H Hoshi, S Nagamachi, S Jinnouchi, L G Flores, S Futami, K Watanabe.   

Abstract

UNLABELLED: The purpose of this study is to clarify the changes of hippocampal perfusion in neuropsychiatric diseases, including dementia, compared with control subjects, and to correlate hippocampal perfusion with the dementia rating scale and the severity of memory disturbance in patients with these diseases.
METHODS: A total of 45 right-handed patients were investigated (13 with dementia of Alzheimer type, 6 with multi-infarct dementia, 4 with progressive dementia with motor neuron disease (MND), 3 with transient global amnesia, 5 with other diseases and 14 control subjects). Regional cerebral blood flow (rCBF) in the parietal cortex and hippocampus was evaluated by high-resolution SPECT technique with HMPAO in all subjects.
RESULTS: The rCBF measurements in the bilateral parietal cortices and hippocampus were lower in dementia of Alzheimer type and multi-infarct dementia patients than in controls. Hypoperfusion in the hippocampus was a more sensitive marker than hypoperfusion in the parietal cortex in diagnosing dementia of Alzheimer type. Hippocampal hypoperfusion was observed in demented patients regardless of etiology and in patients having memory disturbance without dementia, such as transient global amnesia. Finally, hippocampal hypoperfusion reflected the severity of dementia and memory disturbance regardless of etiology.
CONCLUSION: The rCBF image with high-resolution SPECT system may be useful in assessing the extent of dementia and memory disturbance in patients with neuropsychiatric diseases.

Entities:  

Mesh:

Year:  1995        PMID: 7790939

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

Review 1.  Transient global amnesia: implicit/explicit memory dissociation and PET assessment of brain perfusion and oxygen metabolism in the acute stage.

Authors:  F Eustache; B Desgranges; M C Petit-Taboué; V de la Sayette; V Piot; C Sablé; G Marchal; J C Baron
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

2.  Temporal lobe abnormalities in dementia and depression: a study using high resolution single photon emission tomography and magnetic resonance imaging.

Authors:  K P Ebmeier; N Prentice; A Ryman; E Halloran; J E Rimmington; J K Best; G M Goodwin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

3.  Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment.

Authors:  A Cappa; M L Calcagni; G Villa; A Giordano; C Marra; G De Rossi; M Puopolo; G Gainotti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

4.  The development of new method to differentiate between Dementia with Lewy bodies and Alzheimer's disease by cerebral perfusion SPECT-comparison to CIScore.

Authors:  Gaku Honda; Shigeki Nagamachi; Masanari Nonokuma; Koichi Takano; Yasuo Kuwabara; Kengo Yoshimitsu; Hitoshi Iida; Koji Ogomori; Hiroaki Kawasaki; Yoshio Tsuboi
Journal:  Jpn J Radiol       Date:  2020-09-16       Impact factor: 2.374

5.  Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  Michinobu Nagao; Yoshifumi Sugawara; Manabu Ikeda; Ryuji Fukuhara; Kazuhiko Hokoishi; Kenya Murase; Teruhito Mochizuki; Hitoshi Miki; Takanori Kikuchi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

6.  Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study.

Authors:  G E J Garrido; S S Furuie; C A Buchpiguel; C M C Bottino; O P Almeida; C G Cid; C H P Camargo; C C Castro; M F Glabus; G F Busatto
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

Review 7.  Functional neuroimaging in Alzheimer's disease.

Authors:  Hiroshi Matsuda
Journal:  Radiat Med       Date:  2006-05

8.  Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Ibrahim González-Marrero; Lydia Giménez-Llort; Conrad E Johanson; Emilia María Carmona-Calero; Leandro Castañeyra-Ruiz; José Miguel Brito-Armas; Agustín Castañeyra-Perdomo; Rafael Castro-Fuentes
Journal:  Front Cell Neurosci       Date:  2015-02-06       Impact factor: 5.505

9.  Cerebral Perfusion Insufficiency and Relationships with Cognitive Deficits in Alzheimer's Disease: A Multiparametric Neuroimaging Study.

Authors:  Chi-Wei Huang; Shih-Wei Hsu; Ya-Ting Chang; Shu-Hua Huang; Yung-Cheng Huang; Chen-Chang Lee; Wen-Neng Chang; Chun-Chung Lui; Na-Ching Chen; Chiung-Chih Chang
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

10.  miR‑134‑5p/Foxp2/Syn1 is involved in cognitive impairment in an early vascular dementia rat model.

Authors:  Xin Liu; Ruilin Zhang; Zimei Wu; Wenwen Si; Zhenxing Ren; Saixia Zhang; Jianhong Zhou; Dongfeng Chen
Journal:  Int J Mol Med       Date:  2019-09-05       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.